1. Home
  2. INZY vs IROQ Comparison

INZY vs IROQ Comparison

Compare INZY & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • IROQ
  • Stock Information
  • Founded
  • INZY 2015
  • IROQ 1883
  • Country
  • INZY United States
  • IROQ United States
  • Employees
  • INZY N/A
  • IROQ N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • IROQ Savings Institutions
  • Sector
  • INZY Health Care
  • IROQ Finance
  • Exchange
  • INZY Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • INZY 64.9M
  • IROQ 75.8M
  • IPO Year
  • INZY 2020
  • IROQ 2011
  • Fundamental
  • Price
  • INZY $0.92
  • IROQ N/A
  • Analyst Decision
  • INZY Strong Buy
  • IROQ
  • Analyst Count
  • INZY 9
  • IROQ 0
  • Target Price
  • INZY $17.22
  • IROQ N/A
  • AVG Volume (30 Days)
  • INZY 453.8K
  • IROQ 2.0K
  • Earning Date
  • INZY 05-06-2025
  • IROQ 04-29-2025
  • Dividend Yield
  • INZY N/A
  • IROQ 1.70%
  • EPS Growth
  • INZY N/A
  • IROQ 56.77
  • EPS
  • INZY N/A
  • IROQ 0.95
  • Revenue
  • INZY N/A
  • IROQ $24,226,000.00
  • Revenue This Year
  • INZY N/A
  • IROQ N/A
  • Revenue Next Year
  • INZY N/A
  • IROQ N/A
  • P/E Ratio
  • INZY N/A
  • IROQ $24.76
  • Revenue Growth
  • INZY N/A
  • IROQ 8.37
  • 52 Week Low
  • INZY $0.72
  • IROQ $14.85
  • 52 Week High
  • INZY $6.24
  • IROQ $25.76
  • Technical
  • Relative Strength Index (RSI)
  • INZY 44.29
  • IROQ 46.42
  • Support Level
  • INZY $0.83
  • IROQ $23.01
  • Resistance Level
  • INZY $1.08
  • IROQ $24.20
  • Average True Range (ATR)
  • INZY 0.11
  • IROQ 0.40
  • MACD
  • INZY 0.02
  • IROQ -0.06
  • Stochastic Oscillator
  • INZY 55.43
  • IROQ 21.34

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

Share on Social Networks: